Radius’ rookie win
How Radius got exclusive status for Tymlos with Express Scripts
By coming in with a low list price designed to reduce out-of-pocket costs for Medicare patients, Radius Health Inc. also managed the rare feat of getting exclusive placement on Express Scripts Holding Co.’s formulary just months into the launch of Tymlos abaloparatide-SC.
Express Scripts uses excluded drugs lists and exclusive formulary status to manage costs in therapeutic categories where more than one drug is approved.
The PBM’s P&T committee first determines which drugs in a given category are clinically equivalent. Those drugs